Why the study?
What are the acute cardiovascular effects of intravenous acebutolol in patients with and without coronary artery disease?
What are the acute cardiovascular effects of intravenous acebutolol in patients with and without coronary artery disease?
Intravenous acebutolol exerts a small negative inotropic effect that is more pronounced at higher doses and in patients with underlying ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
May warrant caution with IV acebutolol in ischemic heart disease; leaves open need for randomized outcome trials.
Dalal et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: